CRP and rheumatoid arthritis: At the end of the two‐year extension study, participants with RA showed significant improvements in CRP and HDL cholesterol, whereas participants with MSOA had significant reductions in weight, BMI, waist circumference, and diastolic blood pressure compared to the start of intervention.